These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36186195)

  • 1. Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report.
    Zhu SG; Li HB; Dai TX; Li H; Wang GY
    World J Clin Cases; 2022 Sep; 10(27):9743-9749. PubMed ID: 36186195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
    Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
    Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Camrelizumab combined with gemcitabine and oxaliplatin in the treatment of advanced intrahepatic cholangiocarcinoma: a case report and literature review.
    Zhang Z; Wang X; Li H; Sun H; Chen J; Lin H
    Front Immunol; 2023; 14():1230261. PubMed ID: 37671157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of rapidly progressing sarcomatous intrahepatic cholangiocarcinoma with suddenly appearing lymph node metastasis.
    Kanemitsu E; Takahashi R; Nakanishi S; Sueyoshi S; Kobayashi A; Nishimura T; Nagata H
    Surg Case Rep; 2024 Jan; 10(1):9. PubMed ID: 38185762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma.
    Shimamaki Y; Hosokawa I; Takayashiki T; Takano S; Sonoda I; Ohtsuka M
    Surg Case Rep; 2024 Feb; 10(1):35. PubMed ID: 38332333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathological complete response to primary tumor and intrahepatic metastasis treated by gemcitabine plus cisplatin chemotherapy and radical surgery.
    Shibata Y; Sudo T; Tazuma S; Tazawa H; Suzuki T; Onoe T; Shimizu Y; Tashiro H; Kuraoka K; Takahashi S
    Clin J Gastroenterol; 2023 Feb; 16(1):81-86. PubMed ID: 36239900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.
    Liu X; Yao J; Song L; Zhang S; Huang T; Li Y
    J Immunother Cancer; 2019 Aug; 7(1):204. PubMed ID: 31383016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report.
    Takayanagi R; Takano S; Sugiura K; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Kato A; Miyazaki M; Ohtsuka M
    Surg Case Rep; 2017 Nov; 3(1):116. PubMed ID: 29164423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after surgical resection for recurrent hepatic and pulmonary metastases of intrahepatic cholangiocarcinoma: a case report.
    Yamada M; Arimoto A; Toyoda Y; Watanabe S; Aizu K; Sato F; Fujieda A; Yamaguchi R
    Surg Case Rep; 2019 Aug; 5(1):135. PubMed ID: 31432273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant response to transarterial chemoembolization combined with PD-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review.
    Zhang H; Han C; Zheng X; Zhao W; Liu Y; Ye X
    J Cancer Res Ther; 2023 Aug; 19(4):1055-1060. PubMed ID: 37675736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
    Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
    Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
    World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transverse colon invasion from intrahepatic cholangiocarcinoma with lymph node metastasis in the regional mesocolon: a case report.
    Aso K; Ito K; Takemura N; Inagaki F; Mihara F; Kokudo N
    Surg Case Rep; 2020 Oct; 6(1):248. PubMed ID: 33000392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgical resection after neoadjuvant chemoradiation therapy for locally advanced intrahepatic cholangiocarcinoma.
    Kato H; Tabata M; Kobayashi M; Ohsawa I; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    Clin J Gastroenterol; 2009 Oct; 2(5):351-354. PubMed ID: 26192612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
    Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
    World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 18. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
    Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG
    Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
    Shimizu J; Hayashi S; Dono K; Yasumoto T; Zenitani M; Munakata K; Watanabe N; Takamoto K; Kagawa Y; Hata T; Kawanishi K; Ikeda K; Fujita J; Akagi K; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2380-2. PubMed ID: 20037429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case.
    Tsunematsu M; Haruki K; Sakamoto T; Uwagawa T; Shiba H; Yanaga K
    Surg Case Rep; 2019 Jun; 5(1):103. PubMed ID: 31236705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.